Intuitive announced that the Food and Drug Administration recently cleared the da Vinci SP surgical system for simple prostatectomy as a representative procedure, which expands the urologic surgical procedures cleared by FDA. Simple prostatectomy is a surgical procedure often used in patients with benign prostatic hyperplasia or enlarged prostate. In this procedure, the surgeon removes the part of an enlarged prostate that is blocking the flow of urine. In the same action, the FDA cleared the da Vinci SP surgical system for transvesical approach to simple and radical prostatectomy using the da Vinci SP.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ISRG:
- Intuitive receives FDA clearance of da Vinci SP for simple prostatectomy
- Boston Scientific commentary lowers odds of ShockWave deal, says Evercore
- Intuitive Surgical director sells $2.42M in common stock
- VP of Intuitive Surgical McAdams sells $2.9M in shares
- Intuitive Surgical price target raised to $350 from $325 at Bernstein